Past Editions

2024 EDITION

Lifetime management of cardiovascular risk and disease – from the young to the elderly

We are delighted to reflect on the success of the 2nd edition of the “Prevention & Intervention – where preventive cardiology meets interventional cardiology” conference. Building on the impactful first edition, which was dedicated to Women’s Health, we continued our mission to bridge the latest in cardiovascular care with a focus on both prevention and intervention.

In 2024 year, our focus shifted to the encompassing theme of “Lifetime management of cardiovascular risk and disease – from the young to the elderly”. Cardiovascular health was considered from early adulthood and throughout life, highlighting that younger patients often constitute a population that is underdiagnosed and undertreated.

In addition to the high-caliber lectures, we were thrilled to introduce a practical dimension through interactive WORKSHOPS. These sessions offered hands-on experience and actionable insights into the latest strategies and techniques for managing cardiovascular risks and diseases across ages.

We are grateful for the opportunity to have shared knowledge, networked with peers, and explored the future of holistic cardiac care. Thank you to all who participated, and we look forward to welcoming you again in Warsaw next time!

Mirvat Alasnag

Svetlana Apostolovic

Aleksander Araszkiewicz

Maciej Banach

Marta Bande

Shrilla Banerjee

Agnieszka Bartczak-Rutkowska

Stanisław Bartuś

Kiersten Betzer

Agata Bielecka-Dąbrowa

Piotr Buchta

Dorota Bujacz

Davide Capodanno

Jelena Čelutkienė

Alaide Chieffo

Fizzah Choudry

Michał Czapla

Renata Dąbrowska

Maciej Dąbrowski

Magdalena Daccord

Aleksandra Djokovic

Anna Draus

Dariusz Dudek

Magdalena Dudek

Michał Farkowski

Elżbieta Gelert

Marek Gierlotka

Robert J. Gil

Agnieszka Gorgoń-Komor

Paulina Gorzelak-Pabiś

Sebastian Góreczny

Marcin Grabowski

Dorota Gródecka

Lynne Hinterbuchner

Katarzyna Holcman

Zenon Huczek

Sylwia Iwańczyk

Miłosz Jaguszewski

Ewa Jędrzejczyk-Patej

Loreta Kallirroi Kalantzi

Karol Kamiński

Agnieszka Kapłon-Cieślicka

Agnieszka Katarzyńska-Szymańska

Jacek Kądziela

Daria Keller

Katarzyna Kołczewska

Mila Kovacevic

Paweł Kralisz

Mariusz Kruk

Karolina Kryczka

Aleksandra Kudła-Uchwat

Wiktor Kuliczkowski

Vijay Kunadian

Anna Kurek

Marcin Kurzyna

Anna Kwiecień

Ekaterini Lambrinou

Jacek Legutko

Radosław Lenarczyk

Maciej Lesiak

Cecilia Linde

Agata Łapińska-Smolińska

Mamas Mamas

Stephane Manzo-Silberman

Maciej Marciniak

Michał Mazurek

Louise McKenna

Roxana Mehran

Erin D. Michos

Carmen Moldovan

Jakub Morze

Jens Cosedis Nielsen

Tadeusz Osadnik

Michael Papadakis

Valeria Paradies

Biljana Parapid

Radosław Parma

Tomasz Pawłowski

Katarzyna Piaseczyńska

Ewa Piotrowicz

Aleksander Prejbisz

Marcin Protasiewicz

Piotr Przybyłowski

Łukasz Pyka

Anna Pyłko

Adam Rdzanek

Grażyna Rubiś-Liolios 

Nicola Ryan

Pierre Sabouret

Antonia Sambola

Piotr Scisło

Jolanta Siller-Matula

Zbigniew Siudak

Sylwia Sławek-Szmyt

Ilona Stawczyk

Janina Stępińska

Sebastian Szmit

Mariusz Tomaniak

Olga Turowska

Christophe Vandenbriele

Natalia Vanyagina

Agnieszka Witkowska

Wojciech Wojakowski

Agnieszka Wołczenko

Michał Wróbel

October 11, 2024      /      Friday

MAIN STAGE

13:50 – 15:10

Young Hearts at Risk:
Epidemiology of cardiovascular disease in young adults

Chair:
Erin D. Michos
Aleksander Prejbisz (Member of Scientific Council of The Polpharma Foundation)

Panel:
Agata Bielecka-Dąbrowa
Biljana Parapid
Nicola Ryan


Global burden of cardiovascular disease in young adults

Bartosz Hudzik


Assessment of lifetime cardiovascular risk

Erin D. Michos


Cardiovascular disease management in patients with cancer

Mamas Mamas


Novel interventional approaches to CVD

Michał Hawranek


Inflammation as cardiovascular risk factor

Maciej Banach

Sponsored by Novo Nordisk

15:10 – 16:00
Break
* A light lunch will be served from 1:30 PM to 4:30 PM
on the conference floor (1st floor) *

16:00 – 17:20

Integrative Strategies in Cardiology:
Bridging antithrombotic therapy and frailty across the lifespan

Chair:
Robert J. Gil
Bartosz Hudzik
Izabella Uchmanowicz

Panel:
Jelena Celutkiene
Marek Gierlotka
Zbigniew Siudak
Mariusz Tomaniak


Beyond aspirin: the evolution of non-aspirin antiplatelet strategies in coronary artery disease

Mamas Mamas


Frailty across ages: from young adults to the elderly in cardiovascular care

Izabella Uchmanowicz


Strategies for the reversal of novel oral anticoagulants in emergency situations, including the latest reversal agents and protocols

Loreta Kallirroi Kalantzi


Minimally invasive valve repairs in frail patients: Selecting antithrombotic agents for percutaneous aortic and mitral interventions

Robert J. Gil

17:20 – 17:40
Break

17:40 – 19:00

Cardiometabolic Crossroads in Young Adults:
Prevention, intervention, and management

Chair:
Bartosz Hudzik
Mamas Mamas
Zbigniew Siudak

Panel:
Maciej Banach
Aleksander Prejbisz
(Member of Scientific Council of The Polpharma Foundation)


Overweight/obesity – a growing risk factor of CVD

Zbigniew Siudak


Prediabetes and diabetes mellitus – global pandemic in young adults

Carmen Moldovan


Hypertension – a global pandemic

Biljana Parapid


Hypercholesterolemia

Pierre Sabouret

WORKSHOPS  &  NETWORKING

8:30 – 13:30
Hands-on Workshop I

Crack-the-calcium – from diagnosis to management of the calcified lesions

Chair: Michał Hawranek, Marta Kałużna-Oleksy, Paweł Kralisz


PART 1

Coronary and Extracoronary Calcium – pathophysiology, diagnosis & consequences – Fizzah Choudry (15 min.)

Coronary Calcium Management – lifestyle and pharmacotherapy – Aleksander Prejbisz (15 min.)


PART 2

Imaging of the coronary calcium

– CT – Agnieszka Witkowska (12 min.)

– Angiography – Michał Wróbel (12 min.)

– IVUS – Maciej Lesiak (12 min.)

– OCT – Łukasz Pyka (12 min.)

Hands on imaging simulators (27 min.)


PART 3

Crack the calcium: Tools – tips&tricks

– Baloons – Anna Draus (10 min.)

– Atherectomy – Paweł Kralisz (10 min.)

– Laser – Tomasz Pawłowski (10 min.)

Hands on calcium debulking simulators (30 min.)


PART 4
INTRAVASCULAR LITHOTRIPSY SCHOOL

(session granted by Shockwave)

Chair: Marta Kałużna-Oleksy, Michał Hawranek
  1. Introduction to Intravascular Lithotripsy (IVL) – Michał Hawranek (10 min.)
    • What is IVL? Technology and basic principles
    • Mechanism of Action: How IVL works to modify calcified plaques
  1. Clinical Outcomes and Evidence Base for IVL – Marta Kałużna-Oleksy (10 min.)
    • Clinical Trials and Studies: Review of major studies and outcomes data
    • Safety and Efficacy: Complications, success rates, and long-term outcomes
    • Comparative Effectiveness: IVL vs. other techniques like atherectomy and rotational ablation
  1. IVL in practice – tips & triks (case – based) – Marta Kałużna-Oleksy & Michał Hawranek (30 min.)
    • How to deal with Shockwave balloon
    • In-stent restenosis
    • Bifurcation
    • LM
    • Safety points
    • Own-case experience – discussion with participants

Hands on calcium debulking simulators (50 min.)


PART 5

Procedure strategy – when to use which method and how to interpret the images – Stanisław Bartuś (20 min.)

8:30 – 13:30
Hands-on Workshop II

From baseline to residual risk – imaging, lipids and inflammation – how to estimate CV risk in an integrated way

Chair: Erin D. Michos, Izabella Uchmanowicz

PART 1

Workshop under the patronage of Novo Nordisk
Jakub Morze

Inflammation and its role in the development of atherosclerotic diseases – how to investigate and treat (15 min.)

– Clinical cases – characteristics and clinical problems (10 min.)
– Case interpretation by the participants (20 min.)
– Case solutions (10 min.)
– Key learnings (5 min.)


PART 2

Cezary Kępka, Mariusz Kruk

The role of CT in coronary artery disease diagnosis and risk assessment (15 min.)

– Clinical cases – characteristics and clinical problems
– Hands on CT simulators
– Case solutions
– Key learnings 


PART 3

Sanofi

Addressing hypercholesterolemia – state of the art in the diagnosis, risk assessment and treatment of lipid disorders – Maciej Banach (15 min.)

– Clinical cases – characteristics and clinical problems (10 min.)  – Tadeusz Osadnik / Marta Kałużna-Oleksy
– Case interpretation by participants (20 min.)
– Case solutions (10 min.)
– Key learnings (5 min.)

ESC news – hypercholesterolemia –  Marta Kałużna-Oleksy (15 min.)


PART 4

Session wrap-up – Erin D. Michos

13:30 – 14:00
Break

14:00 – 15:30

Pacjent w centrum – zdrowe serce przez całe życie, od profilaktyki do leczenia, edukacja w medycynie

Prowadzenie:
Marta Sułkowska

Panel:
Magdalena Daccord, Elżbieta Gelert, Agnieszka Gorgoń-Komor, Marek Gierlotka, Marta Kałużna-Oleksy, Izabella Uchmanowicz, Agnieszka Wołczenko

Sesja w j. polskim Session in Polish

Sesja z udziałem przedstawicieli organizacji pacjenckich oraz przedstawicieli instytucji działających w zakresie opieki zdrowotnej.

Tematyka poświęcona kompleksowemu podejściu do zdrowia serca, które stawia pacjenta w centrum uwagi. W trakcie sesji omawiane będą kluczowe aspekty profilaktyki chorób sercowo-naczyniowych, nowoczesnych metod diagnostycznych oraz najnowszych osiągnięć w leczeniu chorób serca i naczyń. Sesja ma na celu wskazać, jak prawidłowo zarządzać zarówno ryzykiem, jak i chorobą sercowo-naczyniową na każdym etapie życia, rozpoczynając od najmłodszych lat oraz podkreślić znaczenie współpracy pacjenta z zespołem medycznym w dążeniu do optymalnych wyników zdrowotnych.

  • Sesja z udziałem przedstawicieli organizacji pacjenckich i przedstawicieli instytucji działających w zakresie opieki zdrowotnej.
  • Zarządzanie ryzykiem oraz chorobami sercowo-naczyniowymi na każdym etapie życia
  • Pacjent w centrum zespołu medycznego – klucz do sukcesu
  • Współpraca z organizacjami pacjenckimi i decydentami w zakresie edukacji i szeroko rozumianej profilaktyki
  • Profilaktyka jako kluczowa interwencja, żeby zachować zdrowie

15:30 – 16:15
Break

16:15 – 17:15
Networking session 

Biznes w medycynie: innowacje i nauka – kobieta liderka

Prowadzenie:
Aleksandra Kudła-Uchwat (Anmar)

Panel:
Dorota Bujacz (Symico)
Michał Hawranek
Marta Kałużna-Oleksy
Katarzyna Kołczewska (Procardia)
Agata Łapińska-Smolińska (Naukowa Fundacja Polpharmy)
Grażyna Rubiś-Liolios
(GE)

Sesja w j. polskim

17:15 – 17:30
Break

17:30 – 19:00

Innovations in interventional cardiology – FDA breakthrough technology

Chair:
Michał Hawranek


The role of vasomotor function of the vessel in the development and progression of atherosclerosis

Roxana Mehran


DynamX Bioadaptor platform – mechanism of action and clinical evidence

Michał Hawranek


Clinical cases

Michał Hawranek & Marta Kałużna-Oleksy & Łukasz Pyka


Session wrap-up

Roxana Mehran

October 12, 2024      /      Saturday

MAIN STAGE

09:00 – 10:20

Bridging the Gap:
Innovative strategies in ischemic heart disease management

Chair:
Mirvat Alasnag, Maciej Marciniak

Panel:
Marta Kałużna-Oleksy, Ekaterini Lambrinou, Mariusz Tomaniak


MI in young adults and remature ASCVD – similarities and differences

Shrilla Banerjee


MINOCA and SCAD

Mirvat Alasnag


ANOCA/INOCA

Mariusz Tomaniak


Standard and novel approaches to interventional treatment

Michał Hawranek

10:20 – 10:40

Opening Ceremony

10:40 – 12:00

Navigating the Beat:
Cardiac arrhythmias in the XXI century – from the young to the old

Chair:
Cecilia Linde, Jens Cosedis Nielsen, Radoslaw Lenarczyk

Panel:
Piotr Buchta, Marcin Grabowski, Ewa Jędrzejczyk-Patej, Michał Mazurek


Does age determine response to cardiac resynchronisation therapy?

Cecilia Linde


Conduction system pacing today – for whom and how?

Jens Cosedis Nielsen


Sudden cardiac death in young athletes – how to assess risk, how to prevent?

Michał Mazurek


Changing epidemiology of atrial fibrillation in the 21st century

Marcin Grabowski

12:00 – 12:20
Break

12:20 – 13:40

Reviving the Heart:
Breakthroughs in understanding and treating heart failure

Chair:
Jelena Celutkiene, Janina Stępińska

Panel:
Lynne Hinterbuchner, Jacek Kądziela, Jacek Niedziela


Diagnosis and treatment advanced and end-stage HF in young adults

Piotr Przybyłowski


Prevention and treatment of cardiotoxicity of anticancer therapies

Sebastian Szmit


The role of genetic testing in modern cardiomyopathy management

Tadeusz Osadnik


Hyperthrophic cardiomyopathy from asymptomatic condition to sudden cardiac death

Katarzyna Holcman

13:40 – 14:40
Lunch

14:40 – 16:00

Call for action: Prevention&Intervention AMI in women

Chair:
Stephane Manzo-Silberman, Izabella Uchmanowicz

Panel:
Shrilla Banerjee, Vijay Kunadian, Biljana Parapid, Pierre Sabouret


Epidemiology of sex discrepancy in MI with interest on social and regional features

Michał Hawranek


Care pathway for MI in Women & prognosis

Valeria Paradies


The role of healthcare providers in coordinated care in women

Marta Kałużna-Oleksy


Call for action: presentation of each toolkit (xX)

Stephane Manzo-Silbermann

16:00 – 16:20
Break

16:20 – 17:40
Women in Cardiology Symposium

Empowering Her Heart:
Strategies for combatting cardiovascular diseases in women

Chair:
Shrilla Banerjee, Vijay Kunadian

Panel:
Stephane Manzo-Silberman, Antonia Sambola

Pregnancy and reproductive risk factors for cardiovascular disease in women

Agata Bielecka-Dąbrowa


Current recommendations for menopausal hormone therapy and contraception – the relationship with CVD health outcomes and risks

Dorota Gródecka

Wykład w j. polskim / Lecture in Polish


Innovations in cardiovascular disease prevention and treatment for women

Stephane Manzo-Silberman


Challenges in everyday practice for patients and women practitioners – togetHER

Roxana Mehran

17:40 – 17:55
Break

17:55 – 19:30
Networking session

Connect not separate – the role of women in the generation gap

Chair:
Aleksandra Kudła-Uchwat (Anmar)


Introductory lecture
Ilona Stawczyk
– Lecturer and Transactional Analyst (WSB Merito University Warsaw)

Wykład w j. polskim / Lecture in Polish


Panel discussion:
Kiersten Betzer (Medtronic)
Renata Dąbrowska (Boston Scientific)
Michał Hawranek
Marta Kałużna-Oleksy
Natalia Vanyagina (Elixir)

WORKSHOPS  &  NETWORKING

9:00 – 11:00
Workshop III 

Optimizing Outcomes: The role of physiology and imaging in enhancing percutaneous coronary intervention safety & efficacy

Chair: Mila Kovacevic
Co-chair: Marta Kałużna-Oleksy, Łukasz Pyka, Nicola Ryan

Programme:

  1. Physiology and imaging in coronary artery diesease – indication and interpretation – Jacek Legutko
  2. Clinical cases x 3 – characteristics and clinical problems – Nicola Ryan / Michał Wróbel / Łukasz Pyka
  3. Case interpretation by the participants
  4. Case solutions: Nicola Ryan / Michał Wróbel / Łukasz Pyka
  5. Key learnings – Marta Kałużna-Oleksy, Jacek Legutko

11:00 – 11:25
Break

11:25 – 12:40
Networking session for all healthcare professionals

Women Leadership – how to overcome the barriers: mentoring, advocating, sponsoring – togetHER. Development of personal and professional skills in the field of leadership in healthcare.

Chair:
Michał Hawranek
Bartosz Hudzik
Marta Kałużna-Oleksy
Izabella Uchmanowicz

Panel:
Shrilla Banerjee
Valeria Paradies

WIC @BostonScientific & @Siemens Healthineers

Join the WIC session to learn how to improve personal skills in the field of leadership in healthcare and to advance into leadership positions in various medical and healthcare professions and to support more women physicians to work with industry and how to strengthen the message regarding diversity, equity and inclusion in cardiology world.


Advocating for change: Promoting diversity, equity, and inclusion in cardiology

Shrilla Banerjee


Sponsorship: Elevating women into leadership positions

Mirvat Alasnag


Collaborating with industry: Enhancing opportunities for women physicians

Marta Bande


Mentoring for success: Building supportive networks in healthcare leadership

Katarzyna Piaseczyńska
(Head of Cardiology at Advanced Therapies for Central Eastern Europe and Central Asia)


Announcement of Mentor-Mentee Program for leadership position @Siemens Healthineers

Louise McKenna
(Senior Vice President, Global Head of Sales and Marketing for Advanced Therapies)

12:40 – 12:50
Break

12:50 – 15:15
Workshop IV

Striking the Balance – Mastering Antithrombotic Therapy: A guide to balancing bleeding and ischemic risks

Chair: Jolanta Siller-Matula
Co-chair: Bartosz Hudzik, Loreta Kallirroi Kalantzi

Programme:

  1. An overview of antithrombotic therapy – mechanisms of action of antiplatelet therapy – Jolanta Siller-Matula (10 min.)
  2. An overview of antithrombotic therapy – mechanism of action of anticoagulant therapy – Loreta Kallirroi Kalantzi (10 min.)
  3. Risk Assessment Tools in Antithrombotic Therapy – Bartosz Hudzik (15 min.)
  4. Complex PCI – ischemic risk matters – Maciej Marciniak (15 min.) 
  5. Personalized approach – How to tailor antithrombotic therapy based on individual patient characteristics, including genetic factors, comorbidities, and patient preferences – case-based discussion:
    – DAPT in high-bleeding risk patient (7+10 min.)
    – DAPT in low-bleeding risk patient (7+10 min.)
    – TAT in high-bleeding risk patient (7+10 min.)
    – TAT in low-bleeding risk patient (7+10 min.)
  6. Does sex matter in antithrombotic management? – Jolanta Siller-Matula  (10 min.)
  7. Session wrap up – Bartosz Hudzik

15:15 – 15:25
Break

15:25 – 17:40
Workshop V

Imaging the Heart: Mastering the art of valvular disease diagnosis

Chair: Agnieszka Kapłon-Cieślicka, Adam Rdzanek, Piotr Scisło

Warsztat w j. polskim / Workshop in Polish


Diagnostics and treatment of valve diseases with special emphasis on the mitral and tricuspid valves – case-based learning: Agnieszka Kapłon-Cieślicka, Piotr Scisło


Percutaneous interventions on the tricuspid valve – new technologies, new challenges – TricValve and edge-to-edge procedures – Adam Rdzanek

17:40 – 18:00
Break

18:00 – 19:20

Enduring Hearts:
Mastering the management of congenital and acquired valvular conditions

Chair:
Dariusz Dudek, Radosław Parma

Panel:
Mirvat Alasnag, Maciej Dąbrowski


GUCH (Grown-Up Congenital Heart Disease) – intervention and prevention

Agnieszka Bartczak-Rutkowska


Aortic valve stenosis

Roxana Mehran


Mitral valve regurgitation

Wojciech Wojakowski


Prevention of infective endocarditis

Janina Stępińska


Valvular heart diseases – TAVI, edge-to-edge in young population – different indications?

Zenon Huczek

October 13, 2024      /      Sunday

MAIN STAGE

09:00 – 09:30

Clinical Trials 2024 Wrap-up

Davide Capodanno
Vijay Kunadian

09:30 – 10:50

Cardiovascular Care Compass:
Navigating 2024 ESC Guidelines

Chair:
Davide Capodanno, Vijay Kunadian

Panel:
Michał Hawranek, Bartosz Hudzik, Izabella Uchmanowicz


Arterial hypertension

Aleksander Prejbisz
(Member of Scientific Council of The Polpharma Foundation)


Atrial fibrillation (AF)

Michał Farkowski


Chronic coronary syndromes

Davide Capodanno


Peripheral arterial and aortic disease

Marta Kałużna-Oleksy

10:50 – 11:10
Break

11:10 – 12:30

Heart in Motion:
The power of physical activity in cardiovascular health

Chair:
Pierre Sabouret

Panel:
Jolanta Siller-Matula


Pushing the boundaries: is there a peak threshold for physical activity?

Ekaterini Lambrinou


Endurance or risk? The reality of marathons and young athletes’ heart health

Radosław Parma


Heart recovery pathways: Tailoring exercise prescription for young adults with cardiovascular disease

Michael Papadakis


Arrhythmia in women, does gender matter?

Ewa Piotrowicz

12:30 – 12:50
Break

12:50 – 14:10

Lifesaving to Life-Changing:
from acute cardiac care to lifetime management

Chair:
Marta Kałużna-Oleksy

Panel:
Shrilla Banerjee, Michał Hawranek, Antonia Sambola, Janina Stępińska


Peripartum cardiomyopathy

Karolina Kryczka


Acute myocarditis

Christophe Vandenbriele


AMI cardiogenic shock

Marek Gierlotka


Strategies for circulatory support

Wiktor Kuliczkowski


Cardiogenic shock in aortic stenosis and mitral regurgitation

Roxana Mehran

14:10 – 14:20
Break

14:20 – 15:40

Gender of the Heart: Exploring cardiovascular health across the gender spectrum

Chair:
Izabella Uchmanowicz

Panel:
Michał Hawranek, Bartosz Hudzik, Marta Kałużna-Oleksy


Introduction to cardiovascular health in transgender and nonbinary populations

Erin D. Michos


Effects of gender-affirming hormone therapy on cardiovascular system – what would I like to know as a cardiologist?

Marta Kałużna-Oleksy


Clinical management of cardiovascular disease in transgender patients

Miłosz Jaguszewski


Building inclusive cardiovascular health programs

Michał Czapla

15:40 – 16:40
Lunch

CASE  CORNER  &  NETWORKING

9:30 – 10:30
Women’s health case corner

Sex-specific risk factors & disorders

Chair:
Magdalena Dudek
Alicja Sołtowska

Experts:
Fizzah Choudry
Stephane Manzo-Silberman

Case presenters:
Agnieszka Katarzyńska-Szymańska
Anna Kurek
Sylwia Sławek-Szmyt

Cases centered around comprehensive management of sex-specific risk factors and disorders addressing strategies for preventing CVD

10:30 – 10:45
Break

10:45 – 12:05

Breathing Life:
Understanding pulmonary circulation

Chair:
Izabella Uchmanowicz, Michał Wróbel

Panel:
Aleksander Araszkiewicz, Sebastian Góreczny, Karol Kamiński, Marcin Kurzyna, Sylwia Sławek-Szmyt


Hereditary and acquired prothrombotic states – diagnosis and management

Bartosz Hudzik


Acute pulmonary embolism – when to treat invasively

Aleksander Araszkiewicz


Chronic thromboembolic pulmonary hypertension (CTEPH) – medical and interventional treatment

Marcin Kurzyna


Pulmonary hypertension and HF

Karol Kamiński


Right ventricular outflow tract dysfunction in adults

Sebastian Góreczny

12:05 – 12:15
Break

12:15 – 13:15
Women’s health case corner

Cardiometabolic diseases

Chair:
Michał Czapla

Experts:
Carmen Moldovan
Aleksander Prejbisz
Izabella Uchmanowicz

Case presenters:
Paulina Gorzelak-Pabiś
Daria Keller
Olga Turowska

Cases focused on: Diabetes Mellitus, Hyperlipidemia, Obesity, Hypertension

13:15 – 13:30
Break

13:30 – 14:30
Women’s health case corner

Coronary artery disease

Chair:
Jacek Kądziela

Experts:
Lynne Hinterbuchner
Mila Kovacevic
Nicola Ryan

Case presenters:
Svetlana Apostolovic
Aleksandra Djokovic
Sylwia Iwańczyk

Cases focused on: ANOCA, INOCA, MINOCA, SCAD

14:30 – 14:45
Break

14:45 – 15:45
Women’s health case corner

Aortic valve stenosis

Chair:
Anna Kwiecień
Łukasz Pyka

Experts:
Maciej Dąbrowski
Zenon Huczek
Valeria Paradies

Case presenters:
Maciej Mazurek
Marcin Protasiewicz
Anna Pyłko

Cases focused on diagnosis and treatment of aortic valve stenosis


TAVI in women in light of new data

Zenon Huczek

Criteria for submission

Women's health case corner Prevention & Intervention 2024 Conference
Cases should describe an original observation concerning diagnosis and treatment of CVD in women for the following branches:

🩺 Sex-specific risk factors & disorders

Cases centered around comprehensive management of sex-specific risk factors and disorders addressing strategies for preventing CVD

🩺 Cardiometabolic diseases

Cases focused on: Diabetes Mellitus, Hyperlipidemia, Obesity, Hypertension

🩺 Coronary artery disease

Cases focused on: ASCVD, ANOCA, INOCA, MINOCA, SCAD

🩺 Aortic valve stenosis

Cases focused on diagnosis and treatment of aortic valve stenosis

Stages

1. Submission of cases

Cases should be sent by abstract@prev-interv.com

They should include an abstract/case description (maximum 250 words).

Submissions must be made between 10.06.2024. – 31.07.2024.

2. Review and selection by the jury

Selected members of the jury, chosen by the Prevention & Intervention Organizing Committee, will be responsible for:

  1. Reviewing all submitted cases and approving those meeting all required criteria.
  2. Selecting 12 best case reports for oral presentation.
  3. Corresponding authors of the approved submissions will be contacted by 15.08.2024.
3. Oral presentation

The authors will present the selected cases at the Prevention & Intervention Summit that will be held on 11th – 13th October, 2024. Case corner is scheduled for 13th October 2024.

A single presentation will be divided in to parts, each 7 minutes with appropriate number of the slides.

Each presentation will be followed by 3 minutes of questions/comments from an assigned expert.

The oral presentations will be recorded and published on the Prevention & Intervention website after the meeting.

Why should you participate in Prevention & Intervention Summit?

Participating in the Prevention & Intervention Summit offers numerous benefits, including:

  1. Expert Insights: Gain valuable knowledge from leading experts in preventive and interventional cardiology.
  2. Networking Opportunities: Connect with healthcare professionals, researchers, and industry leaders from across Central and Eastern Europe.
  3. Latest Research: Stay updated on the latest advancements and research findings in cardiovascular disease prevention and intervention.
  4. Collaborative Environment: Engage in meaningful discussions and collaborations that can lead to innovative solutions in cardiology.
  5. Professional Development: Enhance your skills and expand your professional horizons through workshops, presentations, and interactive sessions.
  6. Impactful Contribution: Contribute to shaping the future of cardiovascular health and disease management through active participation and knowledge sharing.

Join us to be part of a transformative event that bridges preventive and interventional cardiology, fostering a holistic approach to managing cardiovascular health throughout life.

Honorary Patronage

Minister of Science Republic of Poland Prevention & Intervention

Patronage

Cardiac Patient Organizations Patronage

Media Patronage

Gold Sponsor

Silver Sponsor

Supporting Sponsor

Exhibitor

Infarma Prevention & Intervenion 2024